Gian Marco Leggio
Gian Marco Leggio
Email verificata su
Citata da
Citata da
New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs
S Salomone, F Caraci, GM Leggio, J Fedotova, F Drago
British journal of clinical pharmacology 73 (4), 504-517, 2012
Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels
V Micale, L Cristino, A Tamburella, S Petrosino, GM Leggio, F Drago, ...
Neuropsychopharmacology 34 (3), 593-606, 2009
Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats
C Bucolo, GM Leggio, F Drago, S Salomone
Biochemical Pharmacology 84 (1), 88-92, 2012
Dopamine D3 receptor as a new pharmacological target for the treatment of depression
GM Leggio, S Salomone, C Bucolo, C Platania, V Micale, F Caraci, ...
European journal of pharmacology 719 (1-3), 25-33, 2013
The PKCβ/HuR/VEGF pathway in diabetic retinopathy
M Amadio, C Bucolo, GM Leggio, F Drago, S Govoni, A Pascale
Biochemical pharmacology 80 (8), 1230-1237, 2010
Homology modeling of dopamine D 2 and D 3 receptors: molecular dynamics refinement and docking evaluation
CBM Platania, S Salomone, GM Leggio, F Drago, C Bucolo
PloS one 7 (9), e44316, 2012
Behavioral effects of the β3 adrenoceptor agonist SR58611A: Is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
D Consoli, GM Leggio, C Mazzola, V Micale, F Drago
European journal of pharmacology 573 (1-3), 139-147, 2007
Current drug treatments targeting dopamine D3 receptor
GM Leggio, C Bucolo, CBM Platania, S Salomone, F Drago
Pharmacology & Therapeutics 165, 164-177, 2016
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: possible involvement of the endocannabinoid and endovanilloid systems
V Micale, L Cristino, A Tamburella, S Petrosino, GM Leggio, F Drago, ...
Neurobiology of Disease 36 (1), 70-80, 2009
Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone
GM Leggio, G Camillieri, CBM Platania, A Castorina, G Marrazzo, ...
Neuropsychopharmacology 39 (8), 2017-2028, 2014
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis
A Navarria, A Tamburella, FA Iannotti, V Micale, G Camillieri, L Gozzo, ...
Pharmacological research 87, 151-159, 2014
Enhanced cognitive performance of dopamine D3 receptor “knock-out” mice in the step-through passive-avoidance test: assessing the role of the endocannabinoid/endovanilloid systems
V Micale, L Cristino, A Tamburella, S Petrosino, GM Leggio, V Di Marzo, ...
Pharmacological research 61 (6), 531-536, 2010
In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus …
GM Leggio, A Cathala, M Neny, F Rouge‐Pont, F Drago, PV Piazza, ...
Journal of neurochemistry 111 (2), 614-623, 2009
Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST)
GM Leggio, V Micale, F Drago
European Neuropsychopharmacology 18 (4), 271-277, 2008
Neurobiological links between depression and AD: the role of TGF-β1 signaling as a new pharmacological target
F Caraci, SF Spampinato, MG Morgese, F Tascedda, MG Salluzzo, ...
Pharmacological research 130, 374-384, 2018
Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens
GM Leggio, A Cathala, D Moison, KA Cunningham, PV Piazza, ...
Neuropharmacology 56 (2), 507-513, 2009
Cognitive effects of SL65. 0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia
V Micale, GM Leggio, C Mazzola, F Drago
Brain research 1121 (1), 207-215, 2006
Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions
V Micale, A Tamburella, GM Leggio, C Mazzola, VL Volsi, F Drago
Pharmacology Biochemistry and Behavior 90 (3), 463-469, 2008
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy
C Bucolo, G Marrazzo, CBM Platania, F Drago, GM Leggio, S Salomone
Journal of Diabetes Research 2013, 2013
P2X7 receptor antagonism: implications in diabetic retinopathy
CBM Platania, G Giurdanella, L Di Paola, GM Leggio, F Drago, ...
Biochemical Pharmacology 138, 130-139, 2017
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20